To investigate whether GSTA4 is involved in chemoresistance, we determined cell survival rates for HCT116 and HCT116ΔGSTA4 cells after exposure to 5-FU and oxaliplatin, two first-line chemotherapeutic agents for colorectal cancer. Here, GSTA4 is linked to colorectal cancer.